Friday, September 7, 2018

Beximco Pharma’s Nadolol tablets gets approval from US FDA

Beximco Pharmaceuticals Limited received US Food and Drug Administration approval for their Nadolol tablets - 20mg, 40mg and 80m), which are generic equivalent of Bristol-Myers Squibb’s Corgard tablets, for treating high blood pressure and chest pain. This is Beximco Pharma’s fifth Abbreviated New Drug Application approved for the US market since the Company’s oral solid dosage facility was approved by the US FDA in June 2015.

Managing Director of Beximco Pharmaceuticals Nazmul Hassan MP on Sunday expressed his gratitude for the FDA approval.

Beximco Pharmaceuticals is an emerging generic drug player committed to providing access to affordable medicines. Company’s state-of-the-art manufacturing facilities have been accredited by the regulatory authorities of USA, Australia, European Union, Canada, and Brazil, among others, and it currently focuses on building presence in many emerging and developed markets around the world.

The company was initiated by country's first generation businessman Salman F Rahman and Sohail F Rahman. Since 2009, Salman F Rahman has been serving as the private sector development affairs adviser to the Bangladesh Awami League President Sheikh Hasina. And he is acting as the president of several trade bodies including Association of Television Channel Owners.